​Pharmacology - Ondansetron

​Pharmacology - Ondansetron 
An antiemetic medication called ondansetron.

Method of Operation 
At 5-HT3 receptors in the CTZ and at the sensory terminals of vagal afferents in the GIT, there is a competitive antagonism that can be reversed.

Administered orally or intravenously (in the event of vomiting). Four to six hours is the half life. The cytochrome P450 system in the liver does the metabolizing.

Use in Clinical Settings
Chemicals that are cytotoxic and anticancer medications are the primary causes of nausea and vomiting. It is typically administered just prior to the beginning of chemotherapy. In the aftermath of the operation or afterward, nausea and vomiting appeared. In the treatment of motion sickness, little effectiveness.
therapy including radiation

Adverse Effects 
Able to be endured. Headache, GIT upsets.